PI3Kβ and δ inhibitor 20a

CAS No. 1842380-77-1

PI3Kβ and δ inhibitor 20a( —— )

Catalog No. M12847 CAS No. 1842380-77-1

A potent, highly selective PI3Kβ/δ inhibitor with IC50 of 7.8/5.3 nM respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PI3Kβ and δ inhibitor 20a
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, highly selective PI3Kβ/δ inhibitor with IC50 of 7.8/5.3 nM respectively.
  • Description
    A potent, highly selective PI3Kβ/δ inhibitor with IC50 of 7.8/5.3 nM respectively, with liitle to no activity on PI3Kα/γ (IC50=850/>10,000 nM); inhibits the phosphorylation of AKT1 Ser473 in PI3K-dependent cell lines with EC50 of 3.4-7.3 nM, inhibits AKT Ser473 phosphorylation and cell viability of LNCaP tumor cells with EC50 of 7.3 nM and GI50 of 38 nM; demonstrates efficacy in human PTEN-deficient LNCaP prostate carcinoma xenograft tumor model.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    PI3K
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1842380-77-1
  • Formula Weight
    450.259
  • Molecular Formula
    C17H14Cl2FN9O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    FC1=CC(Cl)=C(N=C([C@@H](NC2=C(Cl)C(N)=NC(N)=N2)C)N(C3=NNC=C3)C4=O)C4=C1
  • Chemical Name
    (S)-8-chloro-2-(1-((2,6-diamino-5-chloropyrimidin-4-yl)amino)ethyl)-6-fluoro-3-(1H-pyrazol-3-yl)quinazolin-4(3H)-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Perreault S, et al. J Med Chem. 2017 Feb 23;60(4):1555-1567.
molnova catalog
related products
  • GS-9901

    GS-9901 is a selective, orally active and potent PI3Kδ inhibitor (IC50: 1 nM) for the study of non-Hodgkin's lymphoma and chronic lymphocytic leukemia.

  • Dactolisib

    A potent, dual ATP-competitive pan-class I PI3K and mTOR inhibitor for p110α/γ/δ/β and mTOR(p70S6K) with IC50 of 4 nM /5 nM /7 nM /75 nM /6 nM, respectively.

  • GDC-0084

    A potent, selective, brain penetrant dual inhibitor of class I PI3Ks and mTOR with Ki of 2/46/3/10/70 nM for PI3Kα/β/δ/γ/mTOR, respectively.